The NS5A Inhibitor GS-5885 Is Safe and Well-Tolerated in Over 1000 Patients Treated in Phase 2 Studies Full Written Papers Refereed uri icon

Overview

Authors

  • Authorship

    • EVERSON GT
    • YANG JC
    • MARCELLIN P
    • AFDHAL N
    • LAWITZ E
    • DR Alex Thompson
    • SULKOWSKI MS
    • ZHU Y
    • BRAINARD DM
    • MENDELSON L
    • MCHUTCHISON JG
    • PANG PS

Time

Date/time value

  • 2012

Additional Document Info

Parent Title

  • 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
  • HEPATOLOGY

Volume

  • 56

Issue

  • S1

Publisher

  • John Wiley & Sons